Clinical Trial Update
A clinical trial of dipyridamole eye drops in pterygium and pinguecula was carried out in PGIMER in Chandigarh, India. The study was successful and showed that the eye drops were safe to use, and effective in reducing symptoms and hyperemia (eye redness). Due to the COVID-19 pandemic, publication of the study results has been delayed, and is expected in 2023.
Eye Drop Availability
Since dipyridamole is an already-approved drug molecule, dipyridamole eye drops can be prepared by any compounding pharmacy (also known as “specials manufacturer”) who makes sterile preparations.
You can contact your local ophthalmologist or prescriber to request a referral to such a pharmacy.
A mail-order supplier is also available at expressbuy.shop